Share Us: Subscribe | Contact

Biblio

Export 50 results:

Tagged

Filters: Author is Blennow, Kaj [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

F

M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J., “Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.

H. Zetterberg and Blennow, K., “From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S271-S279, 2018.

G

C. - H. Andersson, Hansson, O., Minthon, L., Andreasen, N., Blennow, K., Zetterberg, H., Skoog, I., Wallin, A., Nilsson, S., and Kettunen, P., “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.

J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.

I

L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.

M. Cam, Durieu, E., Bodin, M., Manousopoulou, A., Koslowski, S., Vasylieva, N., Barnych, B., Hammock, B. D., Bohl, B., Koch, P., Omori, C., Yamamoto, K., Hata, S., Suzuki, T., Karg, F., Gizzi, P., Haber, V. Erakovic, Mihaljevic, V. Bencetic, Tavcar, B., Portelius, E., Pannee, J., Blennow, K., Zetterberg, H., Garbis, S. D., Auvray, P., Gerber, H., Fraering, J., Fraering, P. C., and Meijer, L., “Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1663-1681, 2018.

R. Sala-Llonch, Idland, A. - V., Borza, T., Watne, L. Otto, Wyller, T. Bruun, Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K. Beate, and Fjell, A. Martin, “Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.”, J Alzheimers Dis, vol. 58, no. 3, pp. 829-840, 2017.

S. M. Hoscheidt, Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C. S., Carlsson, C. M., Asthana, S., Johnson, S. C., and Bendlin, B. B., “Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1373-83, 2016.

S. E. Berman, Clark, L. R., Rivera-Rivera, L. A., Norton, D., Racine, A. M., Rowley, H. A., Bendlin, B. B., Blennow, K., Zetterberg, H., Carlsson, C. M., Asthana, S., Turski, P., Wieben, O., and Johnson, S. C., “Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.”, J Alzheimers Dis, vol. 60, no. 1, pp. 243-252, 2017.

L

I. Skoog, Kern, S., Zetterberg, H., Östling, S., Börjesson-Hanson, A., Guo, X., and Blennow, K., “Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1877-1886, 2018.

N

P. Lewczuk, Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S., Engelborghs, S., Teunissen, C. E., Zetterberg, H., Molinuevo, J. Luis, Mroczko, B., Blennow, K., Popp, J., Parnetti, L., Chiasserini, D., Perret-Liaudet, A., Spitzer, P., Maler, J. Manuel, and Kornhuber, J., “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.

P

K. Blennow and Zetterberg, H., “The Past and the Future of Alzheimer's Disease Fluid Biomarkers.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1125-1140, 2018.

B. F. Darst, Koscik, R. L., Racine, A. M., Oh, J. M., Krause, R. A., Carlsson, C. M., Zetterberg, H., Blennow, K., Christian, B. T., Bendlin, B. B., Okonkwo, O. C., Hogan, K. J., Hermann, B. P., Sager, M. A., Asthana, S., Johnson, S. C., and Engelman, C. D., “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.

C. E. Teunissen, Chiu, M. - J., Yang, C. - C., Yang, S. - Y., Scheltens, P., Zetterberg, H., and Blennow, K., “Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1857-1863, 2018.

K. D. Deters, Risacher, S. L., Kim, S., Nho, K., West, J. D., Blennow, K., Zetterberg, H., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., and Saykin, A. J., “Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.

A. - V. Idland, Wyller, T. Bruun, Støen, R., Eri, L. Magne, Frihagen, F., Ræder, J., Chaudhry, F. Abbas, Hansson, O., Zetterberg, H., Blennow, K., Bogdanovic, N., Brækhus, A., and Watne, L. Otto, “Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.”, J Alzheimers Dis, vol. 55, no. 1, pp. 371-379, 2017.

R

P. Johansson, Almqvist, E. G., Bjerke, M., Wallin, A., Johansson, J. - O., Andreasson, U., Blennow, K., Zetterberg, H., and Svensson, J., “Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.

S

V. Leinonen, Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P., Pemberton, D., Koivisto, A. M., Jääskeläinen, J. E., Hiltunen, M., Herukka, S. - K., Blennow, K., Zetterberg, H., Jokinen, P., Rokka, J., Helin, S., Haaparanta-Solin, M., Solin, O., Okamura, N., Kolb, H. C., and Rinne, J. O., “S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.”, J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.

P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.

E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.

U. Smailovic, Kåreholt, I., Koenig, T., Ashton, N. J., Winblad, B., Höglund, K., Nilsson, P., Zetterberg, H., Blennow, K., and Jelic, V., “Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 1, pp. 355-366, 2021.

T

H. Lukkarinen, Tesseur, I., Pemberton, D., van der Ark, P., Timmers, M., Slemmon, R., Janssens, L., Streffer, J., Van Nueten, L., Bottelbergs, A., Rauramaa, T., Koivisto, A. M., Herukka, S. - K., Korhonen, V. E., Junkkari, A., Hiltunen, M., Engelborghs, S., Blennow, K., Zetterberg, H., Kolb, H. C., and Leinonen, V., “Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.

S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.

U

P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., “Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.

Pages